These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34316559)

  • 1. Regulation, risk and safety of Faecal Microbiota Transplant.
    Merrick B; Allen L; Masirah M Zain N; Forbes B; Shawcross DL; Goldenberg SD
    Infect Prev Pract; 2020 Sep; 2(3):100069. PubMed ID: 34316559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal microbiota transplantation in patients with
    Lahtinen P; Mattila E; Anttila VJ; Tillonen J; Teittinen M; Nevalainen P; Salminen S; Satokari R; Arkkila P
    World J Gastroenterol; 2017 Oct; 23(39):7174-7184. PubMed ID: 29093626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
    Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
    Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota Transplantation: Is It Safe?
    Park SY; Seo GS
    Clin Endosc; 2021 Mar; 54(2):157-160. PubMed ID: 33827154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review.
    Hammeken LH; Baunwall SMD; Hvas CL; Ehlers LH
    Health Econ Rev; 2021 Jan; 11(1):3. PubMed ID: 33439367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report.
    Spinner JA; Bocchini CE; Luna RA; Thapa S; Balderas MA; Denfield SW; Dreyer WJ; Nagy-Szakal D; Ihekweazu FD; Versalovic J; Savidge T; Kellermayer R
    Pediatr Transplant; 2020 Feb; 24(1):e13598. PubMed ID: 31617299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
    Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL
    Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the implementation of a multidisciplinary programme of faecal microbiota transplantation by colonoscopy for the treatment of recurrent Clostridium difficile infection.
    López-Sanromán A; Rodríguez de Santiago E; Cobo Reinoso J; Del Campo Moreno R; Foruny Olcina JR; García Fernández S; García García de Paredes A; Aguilera Castro L; Ferre Aracil C; Albillos Martínez A
    Gastroenterol Hepatol; 2017 Nov; 40(9):605-614. PubMed ID: 28433406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent
    Alhifany AA; Almutairi AR; Almangour TA; Shahbar AN; Abraham I; Alessa M; Alnezary FS; Cheema E
    BMJ Open; 2019 Nov; 9(11):e031145. PubMed ID: 31699731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection.
    Jalanka J; Hillamaa A; Satokari R; Mattila E; Anttila VJ; Arkkila P
    Aliment Pharmacol Ther; 2018 Feb; 47(3):371-379. PubMed ID: 29226561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota transplantation: establishment of a clinical application framework.
    Jørgensen SMD; Hansen MM; Erikstrup C; Dahlerup JF; Hvas CL
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):e36-e45. PubMed ID: 28863010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal microbiota transplantation for treatment of recurrent or refractory
    Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
    Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
    Ianiro G; Masucci L; Quaranta G; Simonelli C; Lopetuso LR; Sanguinetti M; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2018 Jul; 48(2):152-159. PubMed ID: 29851107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection--an observational cohort study.
    Satokari R; Mattila E; Kainulainen V; Arkkila PE
    Aliment Pharmacol Ther; 2015 Jan; 41(1):46-53. PubMed ID: 25355279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
    Hui W; Li T; Liu W; Zhou C; Gao F
    PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.